Galaxy Medicare leaves Rs 8.4276 crore working capital unspent
Key highlights
- Galaxy Medicare had used Rs 5.1124 crore of its Rs 17.8632 crore fresh IPO issue by September 30, 2026.
- Galaxy Medicare had deployed Rs 51.20 lakh of its Rs 8.9396 crore working-capital allocation, leaving Rs 8.4276 crore.
- Galaxy Medicare fully used Rs 1.7864 crore for issue expenses and Rs 2.2496 crore for general corporate expenses.
- Galaxy Medicare reported September 2026 half-year revenue of Rs 20.1891 crore and profit after tax of Rs 1.5272 crore.
powered by IRIS

Galaxy Medicare Limited had used Rs 5.1124 crore from its Rs 17.8632 crore fresh IPO issue by September 30, 2026, leaving Rs 8.4276 crore of its Rs 8.9396 crore working-capital allocation unspent. The certified statement reported no deviation or variation from the IPO objects disclosed in the prospectus.
Know Galaxy Medicare inside out
Results, valuation, peers and who's buying, in one view.
How much of Galaxy Medicare's IPO proceeds had been used?
Galaxy Medicare had used Rs 5.1124 crore, or about 29% of the Rs 17.8632 crore fresh issue, as of September 30, 2026. The Rs 12.7508 crore balance consisted of Rs 8.4276 crore allocated to working capital and Rs 4.3232 crore allocated to machinery purchases that had not been used at that date.
The company filed the utilisation statement with the National Stock Exchange of India on November 14, 2026, covering the half year ended September 30, 2026. Galaxy Medicare said there was no deviation or variation in the use of IPO proceeds from the objects stated in its prospectus, and said its Audit Committee and board reviewed the statement on November 14, 2026.
A.K. Sabat & Co., the statutory auditor, issued its certificate on November 14, 2026. Based on procedures performed and management representations, the auditor said nothing had come to its attention suggesting that the utilisation statement was not based on the prospectus, bank statements, vendor invoices and other related records.
Which IPO objects has Galaxy Medicare funded?
Galaxy Medicare had fully used the IPO allocations for issue-related expenses and general corporate expenses, while working-capital and machinery deployment remained partial at September 30, 2026. The company reported full utilisation of Rs 1.7864 crore for issue-related expenses and Rs 2.2496 crore for general corporate expenses.
For capital expenditure, Galaxy Medicare allocated Rs 4.8876 crore to buy machinery for its existing manufacturing facility in Bhubaneswar, Odisha. It had used Rs 56.44 lakh for that purpose, leaving Rs 4.3232 crore, compared with Rs 2.2496 crore already used for general corporate expenses.
Working capital was the largest stated IPO object at Rs 8.9396 crore, or about half of the Rs 17.8632 crore fresh issue. Galaxy Medicare had used Rs 51.20 lakh for working capital, slightly below the Rs 56.44 lakh used for machinery, despite the working-capital allocation exceeding the machinery allocation by Rs 4.052 crore.
The utilisation statement relates to the fresh issue and not shares sold by a promoter through the offer for sale. Galaxy Medicare's financial-results notes say it issued 33.08 lakh equity shares through the IPO on September 17, 2025, at an issue price of Rs 54 per share, including a Rs 44 premium over the Rs 10 face value.
Got a follow-up? Ask IRIS
Where did Galaxy Medicare deploy its working-capital funds?
Galaxy Medicare deployed the full Rs 51.20 lakh of working-capital IPO utilisation into inventories as of September 30, 2026. The detailed certified statement showed no use against trade receivables, short-term loans and advances, or other current assets under the IPO working-capital plan.
The prospectus-based calculation identified current assets of Rs 18.2122 crore, including inventories of Rs 6.6432 crore and trade receivables of Rs 8.7814 crore. It also listed Rs 2.0567 crore of short-term loans and advances and Rs 73.09 lakh of other current assets, while identifying Rs 8.9396 crore as the working-capital gap to be funded by IPO proceeds.
Current liabilities in that calculation totalled Rs 4.1843 crore, comprising trade payables of Rs 1.3677 crore, other current liabilities of Rs 99.73 lakh and short-term provisions of Rs 1.8193 crore. The disclosed net working capital was Rs 14.0279 crore, with Rs 3.7709 crore expected from bank borrowings and Rs 1.3174 crore from internal sources alongside the IPO contribution.
Galaxy Medicare's cash-flow statement recorded a Rs 2.8529 crore increase in inventories for the half year ended September 30, 2026. That period-wide inventory movement is distinct from the Rs 51.20 lakh recorded as IPO-funded working-capital utilisation, which tracks only proceeds applied to the stated IPO object.
What does Galaxy Medicare's half-year performance show?
Galaxy Medicare reported revenue from operations of Rs 20.1891 crore for the half year ended September 30, 2026, compared with Rs 18.7317 crore in the corresponding half year ended September 30, 2025. Revenue increased by Rs 1.4574 crore, while total income rose to Rs 21.2356 crore from Rs 19.0647 crore.
Profit after tax was Rs 1.5272 crore for the September 2026 half year, down from Rs 2.0198 crore a year earlier. Total expenses increased to Rs 19.0553 crore from Rs 16.2882 crore, while cost of materials consumed rose to Rs 13.888 crore from Rs 11.6019 crore; the board approved the results on November 14, 2026.
Galaxy Medicare operates in a single segment, according to its financial-results notes, so it did not disclose segment-level revenue or profit. Cash and cash equivalents stood at Rs 3.21 lakh on September 30, 2026, compared with Rs 8.50 lakh on March 31, 2026, following a net decrease of Rs 5.29 lakh during the half year.
Conclusion
Galaxy Medicare's filing shows that it applied funds to all four stated IPO objects without a reported change in purpose, but deployment varied substantially between them. It completed Rs 4.036 crore of issue-related and corporate spending, while using Rs 1.0764 crore across the Rs 13.8272 crore allocated to working capital and machinery.
The next utilisation disclosure will show whether Galaxy Medicare uses the remaining Rs 8.4276 crore working-capital balance beyond inventory and advances machinery purchases from the Rs 56.44 lakh deployed so far. The current filing does not disclose a completion target for either remaining IPO object.


